Lendinvest PLC (LINV)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 28.50 |
|---|---|
| 52-week range | 23.50 – 39.00 |
| Return, 1 month / 3 months | +0.0% / −3.4% |
| Return, 1 year / 3 years | −24.0% / −6.6% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -35.5% |
| Average daily value traded | 11.93M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
LendInvest is a property finance company based in the United Kingdom. It provides short-term bridging loans and buy-to-let mortgages to landlords, property investors and small developers, funding these loans through its own balance sheet and through an investment platform where outside investors can participate. Its customers are mainly professional property investors and borrowers who need fast, flexible finance for residential and commercial property projects that mainstream lenders may not accommodate.
Lendinvest PLC trades under the code LINV on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lendinvest PLC (LINV) trades on the London Exchange in UK. It last closed at GBX 28.50 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,968 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.0% and over the last three months it fell 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -0.5% | ||
| From 52-week high | -25.0% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.4% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | -24.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.5% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 11.93M GBX | ||
| Zero-volume days | 15.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +0.0% |
| 3 months | −3.4% |
| 6 months | +6.3% |
| 1 year | −24.0% |
| 3 years | −6.6% |
| 5 years | −84.4% |
Signals
| 50-day / 200-day average | 28.91 / 28.65 |
|---|---|
| Golden / death cross (60 days) | Golden, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2023 | GBP 0.0320 |
| 5 Jan 2023 | GBP 0.0130 |
| 25 Aug 2022 | GBP 0.0440 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.